- Home
- ASML vs ABBV Comparison
ASML vs ABBV Comparison
Compare ASML & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASML | ABBV |
|---|---|---|
| Founded | 1984 | 2012 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.4B | 400.9B |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | ASML | ABBV |
|---|---|---|
| Price | $1,065.02 | $230.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 18 |
| Target Price | ★ $1,149.20 | $242.28 |
| AVG Volume (30 Days) | 1.4M | ★ 5.6M |
| Earning Date | 01-28-2026 | 01-30-2026 |
| Dividend Yield | 0.59% | ★ 3.02% |
| EPS Growth | ★ 37.86 | N/A |
| EPS | ★ 28.34 | 1.32 |
| Revenue | $37,666,043,037.00 | ★ $59,644,000,000.00 |
| Revenue This Year | $17.25 | $10.37 |
| Revenue Next Year | $4.75 | $9.41 |
| P/E Ratio | ★ $37.46 | $173.25 |
| Revenue Growth | ★ 22.77 | 7.40 |
| 52 Week Low | $578.51 | $164.39 |
| 52 Week High | $1,141.72 | $244.81 |
Technical Indicators
Market Signals| Indicator | ASML | ABBV |
|---|---|---|
| Relative Strength Index (RSI) | 50.93 | 55.77 |
| Support Level | $1,010.01 | $222.35 |
| Resistance Level | $1,067.16 | $229.47 |
| Average True Range (ATR) | 23.10 | 4.06 |
| MACD | -6.39 | 0.50 |
| Stochastic Oscillator | 44.43 | 95.55 |
Price Performance
Historical ComparisonAbout ASML ASML Holding N.V. New York Registry Shares
ASML is the leader in photolithography systems used in manufacturing semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML's main clients are TSMC, Samsung, and Intel.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.